SpringerLink
Log in

The Pediatric Cardiology Pharmacopeia: 2013 Update

  • Review Article
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

The use of medications plays a pivotal role in the management of children with heart diseases. Most children with increased pulmonary blood flow require chronic use of anticongestive heart failure medications until more definitive interventional or surgical procedures are performed. The use of such medications, particularly inotropic agents and diuretics, is even more amplified during the postoperative period. Currently, children are undergoing surgical intervention at an ever younger age with excellent results aided by advanced anesthetic and postoperative care. The most significant of these advanced measures includes invasive and noninvasive monitoring as well as a wide array of pharmacologic agents. This review update provides a medication guide for medical practitioners involved in care of children with heart diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abdulla R, Young S, Barnes S (1997) The pediatric cardiology pharmacopoeia. Pediatr Cardiol 18:162–183

    Article  PubMed  CAS  Google Scholar 

  2. Alten JA, Benner K, Green K et al (2009) Pediatric off-label use of recombinant factor VIIa. Pediatrics 123:1066–1072

    Article  PubMed  Google Scholar 

  3. Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK (2009) Pediatric off-label use of recombinant factor VIIa. Pediatrics 123(3):1066–1072

    Article  PubMed  Google Scholar 

  4. American Heart Association (2010) Pediatric advanced life support drugs and electrical therapy. In: Hazinski MF (ed) Handbook of emergency cardiovascular care for healthcare providers, AHA, Dallas, pp 72–101

  5. American Heart Association (2006) Pharmacology. In: Ralston M (ed) Pediatric advanced life support provider manual, AHA, Dallas, pp 221–255

  6. Aranda JV, Thomas R (2005) Intravenous ibuprofen for preterm newborns. NeoReviews 6:e516–e522

    Article  Google Scholar 

  7. Artman M (2001) Pharmacologic therapy. In: Allen HD, Gutgesell HP, Clark EB, Driscoll DJ (eds) Moss and Adams’ heart disease in infants, children, and adolescents, 6th edn. Lippincott Williams & Wilkins Publishers, Philadelphia, pp 333–349

    Google Scholar 

  8. Bach DS, American College of Cardiology/American Heart Association (2009) Perspectives on the American College of Cardiology/American Heart Association guidelines for the prevention of infective endocarditis. J Am Coll Cardiol 53:1852–1854

    Article  PubMed  Google Scholar 

  9. Barnes S, Shields B, Bonney W, Hardin J, Abdulla R (2004) The pediatric cardiology pharmacopoeia. Pediatr Cardiol 25:623–646

    Article  PubMed  CAS  Google Scholar 

  10. Barst RJ, Rubin LJ, Long WA et al (1996) A comparison of continuous intravenous epoprostenol (prostacylin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 334:296–301

    Article  PubMed  CAS  Google Scholar 

  11. Barst RJ, Maislin G, Fishman A (1999) Vasodilator therapy for primary pulmonary hypertension in children. Circulation 99:1197–1208

    Article  PubMed  CAS  Google Scholar 

  12. Barst RJ, Ivy D, Gaitan G et al (2012) A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension. Circulation 125:324–334

    Article  PubMed  CAS  Google Scholar 

  13. Beghetti M, Habre W, Friedli B et al (1995) Continuous use of low-dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in pediatric patients. Br Heart J 73:65–68

    Article  PubMed  CAS  Google Scholar 

  14. Bonow RO, Carabello BA, Chatterjee K et al (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Valvular Heart Disease). J Am Coll Cardiol 48:e1–e148

    Article  PubMed  Google Scholar 

  15. Boshkov LK, Kirby A, Shen I, Ungerleider RM (2006) Recognition and management of heparin-induced thrombocytopenia in pediatric cardiopulmonary bypass patients. Ann Thorac Surg 81:S2355–S2359

    Article  PubMed  Google Scholar 

  16. British Cardiac Society Guidelines and Medical Practice Committee (2001) Recommendations on the management of pulmonary hypertension in clinical practice. Heart 86:i1–i13

    Google Scholar 

  17. Bronicki RA, Checchia PA (2006) Vasoactive agents. In: Slonim AD, Pollack MM (eds) Pediatric critical care medicine. Lippincott Williams & Wilkins Publishers, Philadelphia, pp 664–669

    Google Scholar 

  18. Buck ML (2004) Octreotide for the management of chylothorax in infants and children. Pediatr Pharmacother 10:1–4

    Google Scholar 

  19. Buck M (2006) Use of aminocaproic acid in children undergoing cardiac surgery or ECMO. Pediatr Pharmacother 12:1–5

    Google Scholar 

  20. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M et al (1998) Autoimmune-associated congenital heart block: mortality, morbidity, and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 31:1658–1666

    Article  PubMed  CAS  Google Scholar 

  21. Cetta F, Graham LC, Wrona LL et al (2004) Argatroban use during pediatric interventional cardiac catheterization. Cathet Cardiovasc Intervent 61:147–149

    Article  Google Scholar 

  22. Chan V, Tse TF, Wong V (1978) Transfer of digoxin across the placenta and into breast milk. Br J Obstet Gynaecol 85:605–609

    Article  PubMed  CAS  Google Scholar 

  23. Chan SY, Lau W, Wong WH et al (2006) Chylothorax in children after congenital heart surgery. Ann Thorac Surg 82:1650–1656

    Article  PubMed  Google Scholar 

  24. Chauhan S, Bisoi A, Kumar N et al (2004) Dose comparison of tranexamic acid in pediatric cardiac surgery. Asian Cardiovasc Thorac Ann 12:121–124

    PubMed  Google Scholar 

  25. Cheung Y, Leung MP, Yip M (2001) Octreotide for treatment of postoperative chylothorax. J Pediatr 139:157–159

    Article  PubMed  CAS  Google Scholar 

  26. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) The seventh report of the Joint National Committee on prevention. JAMA 289:2560–2571

    Article  PubMed  CAS  Google Scholar 

  27. Choong K, Kissoon N (2008) Vasopressin in pediatric shock and cardiac arrest. Pediatr Crit Care Med 9:372–379

    Article  PubMed  Google Scholar 

  28. Clavecilla SQ, De Marco T (2003) New insights into the treatment of pulmonary arterial hypertension. Formulary 38:150–167

    CAS  Google Scholar 

  29. Cuneo BF, Strasburger JF (2000) Management strategy for fetal tachycardia. Obstet Gynecol 96:575–581

    Article  PubMed  CAS  Google Scholar 

  30. Cuneo BF, Zhao H, Strasburger JF, Ovadia M, Huhta JC, Wakai RT (2007) Atrial and ventricular rate response and patterns of heart rate acceleration during maternal-fetal terbutaline treatment of fetal complete heart block. Am J Cardiol 100:661–665

    Article  PubMed  CAS  Google Scholar 

  31. Dajani AS, Taubert KA, Wilson W et al (1997) Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 277:1794–1801

    Article  PubMed  CAS  Google Scholar 

  32. FDA Drug safety communication (2012) FDA recommends against use of Revatio in children with pulmonary hypertension. Retrieved 2012 at http://www.fda.gov/Drugs/DrugSafety/ucm317123.htm

  33. Flynn JT, Mottes TA, Brophy PD, Kershaw DB, Smoyer WE, Bunchman TE (2001) Intravenous nicardipine for treatment of severe hypertension in children. J Pediatr 139:38–43

    Article  PubMed  CAS  Google Scholar 

  34. Friedman DM, Kim MY, Copel JA, Llanos C, Davis C, Buyon JP (2009) Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study. Am J Cardiol 103:1102–1106

    Article  PubMed  Google Scholar 

  35. Friedman DM, Llanos C, Izmirly PM et al (2010) Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum 62:1138–1146

    Article  PubMed  CAS  Google Scholar 

  36. Frohn-Mulder IM, Stewart PA, Witsenburg M, Den Hollander NS, Wladimiroff JW, Hess J (1995) The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia. Prenat Diagn 15:1297–1302

    Article  PubMed  CAS  Google Scholar 

  37. Geller RJ, Barthold C, Saiers JA, Hall HA (2006) Pediatric cyanide poisoning: causes, manifestations, management, and unmet needs. Pediatrics 118:2146–2158

    Article  PubMed  Google Scholar 

  38. Goldberg DJ, French B, ΜBride MG et al (2011) Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial. Circulation 123:1185–1193

    Article  PubMed  CAS  Google Scholar 

  39. Gunn VL, Nechyba C (2000) The Harriet Lane handbook, 16th edn. Mosby-Year Book, St Louis, pp 575–889

    Google Scholar 

  40. Hansmann M, Gembruch U, Bald R, Manz M, Redel DA (1991) Fetal tachyarrhythmias: transplacental and direct fetal treatment of the fetus: a report of 60 cases. Ultrasound Obstet Gynecol 1:162–170

    Article  PubMed  CAS  Google Scholar 

  41. Haraldsson A, Kieler-Jensen N, Richsten S (1996) Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study. J Cardiothorac Vasc Anesth 10:864–868

    Article  PubMed  CAS  Google Scholar 

  42. Haraldsson A, Kieler-Jensen N, Nathorst-Westfelt U, Bergh C, Richsten S (1998) Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Chest 114:780–786

    Article  PubMed  CAS  Google Scholar 

  43. Haraldsson SA, Kieler-Jensen N, Ricksten SE (2001) The additive pulmonary vasodilatory effects of inhaled prostacylin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension. Anesth Analg 93:1439–1445

    Article  CAS  Google Scholar 

  44. Hegenbarth MA, Committee on Drugs (2008) Preparing for pediatric emergencies: drugs to consider. Pediatrics 121:433–443

    Article  PubMed  Google Scholar 

  45. Hoeper MM, Schwarze M, Ehlerding S (2000) Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med 342:1866–1870

    Article  PubMed  CAS  Google Scholar 

  46. Horstkotte D, Piper C (2009) Guidelines for the prevention of infective endocarditis revised: a critical appraisal of the AHA recommendations and call for an individual approach. J Heart Valve Dis 18:309–313

    PubMed  Google Scholar 

  47. Hsu B, Brazelton T (2009) Off-label medication use in an academic hospital pediatric critical care unit. Wincosin Med J 108:343–348

    Google Scholar 

  48. Hursting M, Dubb J, Verme-Gibboney C (2006) Argatroban anticoagulation in pediatric patients: a literature analysis. J Pediatr Hematol Oncol 281:4–10

    Article  Google Scholar 

  49. Hutchon DJ (1982) Management of severe fetal bradycardia with ritodrine. Br J Obstet Gynaecol 89:671–674

    Article  PubMed  CAS  Google Scholar 

  50. Jaeggi ET, Fouron JC, Silverman ED, Ryan G, Smallhorn J, Hornberger LK (2004) Transplacental treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 110:1542–1548

    Article  PubMed  Google Scholar 

  51. Julkunen H, Eronen M (2001) The rate of recurrence of isolated congenital heart block: a population-based study. Arthritis Rheum 44:487–488

    Article  PubMed  CAS  Google Scholar 

  52. Kelly L, Porta N, Goodman D, Carroll C, Steinhorn R (2002) Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr 141:830–832

    Article  PubMed  CAS  Google Scholar 

  53. Li J, Yow E, Berezny KY (2008) Dosing of clopidogrel for platelet inhibition in infants and young children. Circulation 118:553–559

    Article  Google Scholar 

  54. Lowson SM (2002) Inhaled alternatives to nitric oxide. Anesthesiology 96:1504–1513

    Article  PubMed  CAS  Google Scholar 

  55. Lui HK, Lee G, Dietrich P et al (1982) Flecainide induced QT prolongation and ventricular tachycardia. Am Heart J 103:567–569

    Article  PubMed  CAS  Google Scholar 

  56. MacNeil DJ (1997) The side effect profile of class III drug antiarrhythmic drugs: focus on d, l-sotalol. Am J Cardiol 80:90G–98G

    Article  PubMed  CAS  Google Scholar 

  57. Mangione R, Guyon F, Vergnaud A, Jimenez M, Saura R, Horovitz J (1999) Successful treatment of refractory supraventricular tachycardia by repeat intravascular injection of amiodarone in a fetus with hydrops. Eur J Obstet Gynecol Reprod Biol 86:105–107

    Article  PubMed  CAS  Google Scholar 

  58. Matsubara S, Morimatsu Y, Shiraishi H, Kuwata T, Ohkuchi A, Izumi A, Takeda S, Suzuki M (2008) Fetus with heart failure due to congenital atrioventricular block treated by maternally administered ritodrine. Arch Gynecol Obstet 278:85–88

    Article  PubMed  CAS  Google Scholar 

  59. Maxwell DJ, Crawford DC, Curry PVM et al (1988) Obstetric importance, diagnosis, and management of fetal tachycardias. BMJ 297:107–110

    Article  PubMed  CAS  Google Scholar 

  60. Mertens L, Eyskens B, Boshoff D (2008) Safety and efficacy of clopidogrel in children with heart disease. J Pediatr 153:61–64

    Article  PubMed  CAS  Google Scholar 

  61. Mikhail G, Gibbs S, Richardson G, Wright G, Khaghani A, Banner N (1997) An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension. Eur Heart J 18:1499–1504

    Article  PubMed  CAS  Google Scholar 

  62. Miller OI, Tang SF, Keech A et al (2000) Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomized double-blind study. Lancet 356:1449–1464

    Article  Google Scholar 

  63. Monagle P, Michelson AD, Bovill E, Andrew M (2001) Antithrombotic therapy in children. Chest 119:344S–370S

    Article  PubMed  CAS  Google Scholar 

  64. Munoz R et al (2008) Handbook of pediatric cardiovascular drugs. Springer, London

    Book  Google Scholar 

  65. Newall F, Johnston L, Ignjatovic V et al (2009) Unfractionated heparin therapy in infants and children. Pediatrics 123:e510–e518

    Article  PubMed  Google Scholar 

  66. Nishimura RA, Carabello BA, Faxon DP et al (2008) ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 52:676–685

    Article  PubMed  Google Scholar 

  67. Noel N, Naheed Z (2012) Hypertrophic cardiomyopathy: role of current recommendations by the American Heart Association for infective endocarditis. Pediatr Cardiol. doi:10.1007/s00246-012-0324-6

  68. Odetola FO, Bhatt-Mehta V, Zahraa J, Moler FW, Custer JR (2002) Cisatracurium infusion for neuromuscular blockade in the pediatric intensive care unit: a dose-finding study. Pediatr Crit Care Med 3:250–254

    Article  PubMed  Google Scholar 

  69. Oen EM, Doan KA, Knoderer CA, Knoderer HM (2009) Recombinant factor VIIa for bleeding in nonhemophiliac pediatric patients. J Pediatr Pharmacol 14:38–47

    Google Scholar 

  70. Olschewski H, Walmrath D, Schermuly R et al (1996) Aerosolized prostacylin and iloprost in severe pulmonary hypertension. Ann Int Med 124:820–824

    PubMed  CAS  Google Scholar 

  71. Oudijk MA, Michon MM, Kleinman CS, Kapusta L, Stoutenbeek P, Visser GH, Meijboom EJ (2000) Sotalol in the treatment of fetal dysrhythmias. Circulation 101:2721–2726

    Article  PubMed  CAS  Google Scholar 

  72. Oudijk MA, Ruskamp JM, Ambachtsheer BE, Ververs TF, Stoutenbeek P, Visser GH, Meijboom EJ (2002) Drug treatment of fetal tachycardias. Pediatr Drugs 4:49–63

    Google Scholar 

  73. Oudijk MA, Ruskamp JM, Ververs FFT, Ambachtsheer EB, Stoutenbeek P, Visser GH, Meijboom EJ (2003) Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics. J Am Coll Cardiol 42:765–770

    Article  PubMed  CAS  Google Scholar 

  74. Rayapudi S, Torres A, Deshpande GG et al (2008) Bivalirudin for anticoagulation in children. Pediatr Blood Cancer 5:798–801

    Article  Google Scholar 

  75. Rogers Μ, Willerson JT, Goldblatt A et al (1972) Serum digoxin concentrations in the human fetus, neonate, and infant. N Engl J Med 16:1010–1013

    Article  Google Scholar 

  76. Solina A, Papp D, Ginsberg S, Krause T, Grubb W et al (2000) A comparison of inhaled nitric oxide and milrinone for the treatment of pulmonary hypertension in adult cardiac surgery patients. J Cardiothorac Vasc Anesth 14:12–17

    Article  PubMed  CAS  Google Scholar 

  77. Strasburger JF, Cuneo BF, Michon MM, Gotteiner NL, Deal BJ, ΜGregor SN, Oudijk MA et al (2004) Amiodarone therapy for drug-refractory fetal tachycardia. Circulation 109:375

    Article  PubMed  CAS  Google Scholar 

  78. Susil G (2009) Emergecny management. In: Custer JW, Rau RE (eds) The Harriet Lane handbook, 18th edn. Mosby Elsevier, Philadelphia, pp 3–17

    Google Scholar 

  79. Taketomo CK, Hodding JH, Kraus DM (2008–2009) Pediatric dosage handbook (replaces older version), 15th edn. Lexi-Comp. Inc, Hudson, pp 28–1816

  80. Taubert KA, Gewitz MH (2008) Infective endocarditis. In: Hugh DA, David JD, Robert ES, Timothy FF (eds) Moss and Adams’ heart disease in infants, children, and adolescents, vol 2, 7th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1299–1312

    Google Scholar 

  81. Van den Heuvel F, Bink-Boelkens MT, du Marchie Sarvaas GJ, Berger RM (2008) Drug management of fetal tachyarrhythmias: are we ready for a systematic and evidence-based approach? Pacing Clin Electrophysiol 31(Suppl 1):S54–S57

    Article  PubMed  Google Scholar 

  82. vanOvermeire B, Smets K, Lecoutere D et al (2000) A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 343:674–681

    Article  CAS  Google Scholar 

  83. Vintzileos AM, Campbell WA, Soberman SM et al (1985) Fetal atrial flutter and xlinked dominant vitamin D-resistent rickets. Obstet Gynecol 65(3 Suppl.):39S–44S

    PubMed  CAS  Google Scholar 

  84. Wilson W, Taubert KA, Gewitz M et al (2007) Prevention of infective endocarditis. Guidelines from the American Heart Association. A guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 16:1736–1754

    Article  Google Scholar 

  85. Kaw AD Hematol Oncol Clin North Am 12:445–457

  86. Pediatric off-label use of recombinant factor VIIa

  87. Young G (2008) New anticoagulants in children (2008). Hematology 245(1):245–250

    Article  Google Scholar 

  88. Young G, Wohrley TJ, Weber C et al (2007) Pilot dose-finding and safety study of bivalirudin in infants less than 6 months of age with thrombosis. J Thromb Haemostasis 5:1654–1659

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Rush University Medical Center, 1653 W Congress Parkway, Chicago, IL, 60612, USA

    Paul Nicholas Severin, Sawsan Awad, Beth Shields, Joan Hoffman, Edmundo Cortez, Rani Ganesan, Aloka Patel, Steve Barnes, Umang Gupta, Yolandee Bell Cheddar, Ismael E. Gonzalez, Kiran Mallula, Hani Ghawi, Suhaib Kazmouz, Salwa Gendi & Ra-id Abdulla

  2. Stroger Hospital of Cook County, 1901 W. Harrison Street, Chicago, IL, 60612, USA

    Paul Nicholas Severin, Edmundo Cortez & Rani Ganesan

  3. Department of Cardiology, Children’s Hospital of Philadelphia, 34th Street and Civic Center Blvd, Philadelphia, PA, 19104, USA

    William Bonney

  4. Combined Pediatrics and Anesthesiology Residency Program, Johns Hopkins University, Baltimore, MD, USA

    Sean Barnes

  5. Wisconsin Children’s Hospital, Milwaukee, WI, USA

    Shada Al-Anani

Authors
  1. Paul Nicholas Severin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sawsan Awad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Beth Shields
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joan Hoffman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. William Bonney
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Edmundo Cortez
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rani Ganesan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Aloka Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Steve Barnes
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Sean Barnes
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Shada Al-Anani
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Umang Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Yolandee Bell Cheddar
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Ismael E. Gonzalez
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Kiran Mallula
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Hani Ghawi
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Suhaib Kazmouz
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Salwa Gendi
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Ra-id Abdulla
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul Nicholas Severin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Severin, P.N., Awad, S., Shields, B. et al. The Pediatric Cardiology Pharmacopeia: 2013 Update. Pediatr Cardiol 34, 1–29 (2013). https://doi.org/10.1007/s00246-012-0553-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-012-0553-8

Keywords

Search

Navigation